{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "迈入新一轮新药兑现期，国际化持续提速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2024-04-25 00:00:00.000",
      "infoCode": "AP202404251631282216",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.104",
      "predictThisYearPe": "39.93",
      "predictLastYearEps": "0.716",
      "predictLastYearPe": "61.61",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2382,
      "attachPages": 17,
      "encodeUrl": "OPw8X34UDWQq6g0u70KgHR/itOPCYjXUB2XMO/ZAqL8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩平稳增长，研发稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2024-04-25 00:00:00.000",
      "infoCode": "AP202404251631250484",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 551,
      "attachPages": 4,
      "encodeUrl": "OPw8X34UDWQq6g0u70KgHeAmzLwRXhJFIAMfgZyI3CU=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年报和2024一季报点评：创新药收入占比持续增加，国际化进程稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2024-04-24 00:00:00.000",
      "infoCode": "AP202404241631119948",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2800000000",
      "predictNextYearPe": "34.4000000000",
      "predictThisYearEps": "1.0400000000",
      "predictThisYearPe": "42.3900000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 511,
      "attachPages": 3,
      "encodeUrl": "R27bGYnCfe6g/ZBwiSHjfTE86AoWy/86vpmsG0Yj67c=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，持续加强源头创新",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2024-04-22 00:00:00.000",
      "infoCode": "AP202404211630933719",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.0900000000",
      "predictNextYearPe": "38.1000000000",
      "predictThisYearEps": "0.9200000000",
      "predictThisYearPe": "45.2800000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培",
        "11000398535.孙怡"
      ],
      "indvIsNew": "001",
      "researcher": "程培,孙怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 357,
      "attachPages": 4,
      "encodeUrl": "zrBVIE5sQhS4eyuFUrBpmxQ7uut3dFT2qvqH9Awc9rA=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536",
        "11000398535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药收入快速增长，持续加强源头创新",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2024-04-21 00:00:00.000",
      "infoCode": "AP202404211630895386",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.1300000000",
      "predictNextYearPe": "39.1500000000",
      "predictThisYearEps": "0.9400000000",
      "predictThisYearPe": "47.0500000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1282,
      "attachPages": 6,
      "encodeUrl": "zrBVIE5sQhS4eyuFUrBpmzlI+jPmWmpjUtf+w42/P+Y=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩端稳定增长，快速推进创新成果落地",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银证券",
      "publishDate": "2024-04-18 00:00:00.000",
      "infoCode": "AP202404181630513708",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2000000000",
      "predictNextYearPe": "36.0000000000",
      "predictThisYearEps": "1.0000000000",
      "predictThisYearPe": "43.9000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000296832.刘恩阳",
        "11000450337.薛源"
      ],
      "indvIsNew": "001",
      "researcher": "刘恩阳,薛源",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 535,
      "attachPages": 4,
      "encodeUrl": "O2cri/ehFXSSr5JiKxk2PU5FAAM/udy24d0f6lKzlqk=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000296832",
        "11000450337"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新驱动强劲，出海布局达成多项里程碑",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2024-04-18 00:00:00.000",
      "infoCode": "AP202404181630501119",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2860000000",
      "predictNextYearPe": "34.5200000000",
      "predictThisYearEps": "1.0420000000",
      "predictThisYearPe": "42.6100000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1029,
      "attachPages": 6,
      "encodeUrl": "O2cri/ehFXSSr5JiKxk2PYBvxjrh3CE7EPyqerMvzwI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年员工持股计划点评：2026年创新药收入有望超200亿",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2023-11-06 00:00:00.000",
      "infoCode": "AP202311061609031633",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "0.91",
      "predictThisYearPe": "52.21",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 472,
      "attachPages": 3,
      "encodeUrl": "rmB3SPLw9c6TQ0InLYy9lMJfaIoxIzStSMLYSEaTwYo=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000179188",
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩持续向好，国际化战略稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2023-11-02 00:00:00.000",
      "infoCode": "AP202311021607922376",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.02",
      "predictThisYearPe": "47.13",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1042,
      "attachPages": 4,
      "encodeUrl": "xa4Vj2lH4njDOoJe3pMj9PHLawgqNTcyzCQyC4MiU3o=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "CLDN18.2 ADC和PARP1授权出海，国际化密集兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-11-02 00:00:00.000",
      "infoCode": "AP202311021607920837",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1",
      "predictThisYearPe": "48.14",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1228,
      "attachPages": 5,
      "encodeUrl": "xa4Vj2lH4njDOoJe3pMj9NdfJ5VfGJxtABPBorBbq7U=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Q3业绩继续向好，海外临床及BD取得积极进展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2023-10-27 00:00:00.000",
      "infoCode": "AP202310271605352867",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0900000000",
      "predictThisYearPe": "41.7000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000444154.赵宁达"
      ],
      "indvIsNew": "001",
      "researcher": "赵宁达",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 313,
      "attachPages": 5,
      "encodeUrl": "dKkCDwZKjT55WxBCCU6JcTZoSKyKRP/HqrtdHT6pypk=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000444154"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年三季报点评：业绩稳健增长，创新和国际化快速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-10-27 00:00:00.000",
      "infoCode": "AP202310271605160078",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1",
      "predictThisYearPe": "40.1",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1232,
      "attachPages": 5,
      "encodeUrl": "dKkCDwZKjT55WxBCCU6JcQrNDTsQlFpJmKVQfttdKg8=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "【银河医药】恒瑞医药三季报点评：业绩稳定增长，创新提供内生动力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2023-10-26 00:00:00.000",
      "infoCode": "AP202310261604144442",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0400000000",
      "predictThisYearPe": "41.5500000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培"
      ],
      "indvIsNew": "001",
      "researcher": "程培",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 362,
      "attachPages": 4,
      "encodeUrl": "L6lvWnZiQzKgn5UUDFvOoqJQ8em+dWI7eC/ArQKiDaQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年三季报点评：业绩持续向好，国际化不断推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2023-10-26 00:00:00.000",
      "infoCode": "AP202310261603999436",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0800000000",
      "predictThisYearPe": "40.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 794,
      "attachPages": 3,
      "encodeUrl": "L6lvWnZiQzKgn5UUDFvOonYRZ6GxwEhvhcR3jneu0zE=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年三季报点评：国际化进程持续加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2023-10-26 00:00:00.000",
      "infoCode": "AP202310261603995829",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "0.9100000000",
      "predictThisYearPe": "47.4400000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 461,
      "attachPages": 3,
      "encodeUrl": "L6lvWnZiQzKgn5UUDFvOovKcr4p826md2CSn1Rnh9CE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000179188",
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "营收利润双升，费用率优化，国际化加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-10-26 00:00:00.000",
      "infoCode": "AP202310261603990825",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "0.986",
      "predictThisYearPe": "43.78",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1019,
      "attachPages": 4,
      "encodeUrl": "L6lvWnZiQzKgn5UUDFvOohhwN2BBC/q+RZr7dZS0MVQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "卡瑞利珠单抗联用治疗肝癌签署海外授权协议",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-10-18 00:00:00.000",
      "infoCode": "AP202310181601996795",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "0.986",
      "predictThisYearPe": "45.09",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 873,
      "attachPages": 4,
      "encodeUrl": "PL81kUn9ts2mSwdbSDaCwDzxrO9ZVySzmj/ak0uQNd8=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药：上市创新药增至15个，“双艾”在美申报获受理",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80092742",
      "orgName": "信达证券股份有限公司",
      "orgSName": "信达证券",
      "publishDate": "2023-09-07 00:00:00.000",
      "infoCode": "AP202309071597971485",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.2800000000",
      "predictThisYearPe": "31.9300000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000227620.唐爱金"
      ],
      "indvIsNew": "001",
      "researcher": "唐爱金",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 526,
      "attachPages": 5,
      "encodeUrl": "UWODdgK85d07qOzSAgaOuXx+QLRwaTEmGlCNjDnhLIQ=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000227620"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年中报点评，创新驱动增长，研发进展不断",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2023-08-24 00:00:00.000",
      "infoCode": "AP202308241595688813",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.08",
      "predictThisYearPe": "36",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 898,
      "attachPages": 3,
      "encodeUrl": "3yjC4PkELi+EFH1HkXuQWQTo85GPQk0YIj6tjiK0pqk=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药驱动收入增长，国际化战略稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2023-08-22 00:00:00.000",
      "infoCode": "AP202308221595478371",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文",
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文,李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1064,
      "attachPages": 4,
      "encodeUrl": "Aq7h9CYeKO8i2Kg542hdFimKDWbIIbiKtig6JwrVLDg=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532",
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药收入高增长，管线进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2023-08-22 00:00:00.000",
      "infoCode": "AP202308221595472684",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000252536.程培"
      ],
      "indvIsNew": "001",
      "researcher": "程培",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 799,
      "attachPages": 6,
      "encodeUrl": "Aq7h9CYeKO8i2Kg542hdFuKbVqhPqbAe2nXdm7Vizb8=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Q2净利重回20%增长，在研管线进入密集收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2023-08-22 00:00:00.000",
      "infoCode": "AP202308221595454668",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0900000000",
      "predictThisYearPe": "35.7000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000444154.赵宁达"
      ],
      "indvIsNew": "001",
      "researcher": "赵宁达",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 342,
      "attachPages": 6,
      "encodeUrl": "Aq7h9CYeKO8i2Kg542hdFhrpIm/I68+UyTDAMYpQWzI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000444154"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩重回上升通道，创新和国际化持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-08-21 00:00:00.000",
      "infoCode": "AP202308211595388569",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1233,
      "attachPages": 5,
      "encodeUrl": "fwLCpmIFC628lZpD8R8i3aoQ3dV3HDPOU64E4aLtkB0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2023年中报点评：重回增长轨道，创新药对外授权不断兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2023-08-21 00:00:00.000",
      "infoCode": "AP202308211595387438",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 533,
      "attachPages": 3,
      "encodeUrl": "fwLCpmIFC628lZpD8R8i3fSxqQ7On87DZfjLmoxflCY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司半年报：上半年创新药收入近50亿，仿药收入基本持平",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001968",
      "orgName": "海通国际证券集团有限公司",
      "orgSName": "海通国际",
      "publishDate": "2023-08-21 00:00:00.000",
      "infoCode": "AP202308211595386907",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.2100000000",
      "predictThisYearPe": "32.9400000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000370046.Kehan Meng",
        "11000432537.Yilin Yuan"
      ],
      "indvIsNew": "001",
      "researcher": "Kehan Meng,Yilin Yuan",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "47.9600000000",
      "indvAimPriceL": "47.9600000000",
      "attachType": "0",
      "attachSize": 2271,
      "attachPages": 12,
      "encodeUrl": "fwLCpmIFC628lZpD8R8i3YEbl8UVmjHiGuX4EzYAH10=",
      "sRatingName": "优于大市",
      "sRatingCode": "0401",
      "market": "SHANGHAI",
      "authorID": [
        "11000370046",
        "11000432537"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药临床价值凸显，业绩重回增长轨道",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-08-21 00:00:00.000",
      "infoCode": "AP202308211595381796",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2088,
      "attachPages": 9,
      "encodeUrl": "fwLCpmIFC628lZpD8R8i3UvyZhf+51tep33Grc518/E=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "TSLP单抗授权出海，国际化再下一城",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-08-16 00:00:00.000",
      "infoCode": "AP202308161594842322",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.05",
      "predictThisYearPe": "45.65",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1228,
      "attachPages": 5,
      "encodeUrl": "zmlXsXwIRlunmM9IEWMUODfk9tws09d88FiY2fnka/8=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：TSLP达成海外授权，关注创新药放量及长期成长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2023-08-16 00:00:00.000",
      "infoCode": "AP202308161594835859",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0900000000",
      "predictThisYearPe": "37.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 921,
      "attachPages": 3,
      "encodeUrl": "zmlXsXwIRlunmM9IEWMUOHphd9/Y0CMJwcGijTXAnQE=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "股权激励彰显龙头信心，创新药驱动长期成长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-08-01 00:00:00.000",
      "infoCode": "AP202308011592995144",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.022",
      "predictThisYearPe": "43.64",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1008,
      "attachPages": 4,
      "encodeUrl": "i8/UTOGNrDmqS7UCx7jw7cRE5sPkEfeOlT4FKHoi2Xg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：“双艾”组合数据发表柳叶刀，关注创新药放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2023-07-27 00:00:00.000",
      "infoCode": "AP202307271592714196",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0900000000",
      "predictThisYearPe": "44.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 852,
      "attachPages": 3,
      "encodeUrl": "EHuzTHeoLS2JqFVVSIpjfLwQVMZopIc7fRIdtqrK5yQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：创新药研发持续兑现，关注医保谈判助力放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2023-07-04 00:00:00.000",
      "infoCode": "AP202307041592034270",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.09",
      "predictThisYearPe": "45",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 521,
      "attachPages": 3,
      "encodeUrl": "bVmwsM4E8OjF0/FKn+RvbglY3LnC0oTu5tNwT7vix4Q=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "拟股份回购用于员工持股计划，业绩拐点已现新药可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-05-17 00:00:00.000",
      "infoCode": "AP202305171586711886",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.022",
      "predictThisYearPe": "48.09",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 883,
      "attachPages": 4,
      "encodeUrl": "0AEDg5jhhIajd+TbPbFYYbPA3pCvxNT0D3AfL4gThOc=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：回购股份方案彰显公司长期发展信心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2023-05-16 00:00:00.000",
      "infoCode": "AP202305161586680846",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.0800000000",
      "predictThisYearPe": "43.9300000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 502,
      "attachPages": 3,
      "encodeUrl": "8zVzyxK414lW5bgsv0QzZSdzseyVTBI6f1YwvDFq1QI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000179188",
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩拐点已至，创新和国际化行稳致远",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-04-28 00:00:00.000",
      "infoCode": "AP202304281586091615",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.05",
      "predictThisYearPe": "45.81",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1186,
      "attachPages": 4,
      "encodeUrl": "SBxzy/Sb7G8CXjKs5+K/WnTgyQGu5bsAfjo9LV8NGno=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2022和2023年一季报点评：王者归来，二季度迎接全面复苏",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2023-04-27 00:00:00.000",
      "infoCode": "AP202304271585933285",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.08",
      "predictThisYearPe": "44.56",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 494,
      "attachPages": 3,
      "encodeUrl": "2ylqZV8PYP5Hd5r5/K/zZanyej0KJYybEU+vg4FVGjA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "EZH2授权出海，交易总额有望超7亿美元",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2023-02-15 00:00:00.000",
      "infoCode": "AP202302151583191764",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.68",
      "predictLastYearPe": "64.42",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1195,
      "attachPages": 4,
      "encodeUrl": "V9Js5XfG5pH/GKSwdty0kZsXvuiv+qfrQ569S1Jyyx0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新逐渐开花结果，医药龙头拐点将至",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-02-13 00:00:00.000",
      "infoCode": "AP202302131583076871",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6610000000",
      "predictLastYearPe": "65.9100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 830,
      "attachPages": 4,
      "encodeUrl": "bzZqtr/IfnTrAp3bhI/vk54bHi2Tqx3b99LT4FKxfXE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "新药获批，看好公司长期成长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2023-01-16 00:00:00.000",
      "infoCode": "AP202301161582051169",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.57",
      "predictLastYearPe": "69.32",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 0,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "50.0000000000",
      "indvAimPriceL": "50.0000000000",
      "attachType": "0",
      "attachSize": 503,
      "attachPages": 3,
      "encodeUrl": "unrH82KiczoXbloJmQeO3Y2q9LlRFn2GlcG/rIQ0HWI=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药加速放量在即，经营拐点渐现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2023-01-13 00:00:00.000",
      "infoCode": "AP202301131581960803",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.6610000000",
      "predictLastYearPe": "58.1300000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "52.3000000000",
      "indvAimPriceL": "52.3000000000",
      "attachType": "0",
      "attachSize": 2960,
      "attachPages": 28,
      "encodeUrl": "RGT0TZBJm469OBAvS19CwyPYxZoYCjU5Z1EUxwfDu40=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "环比业绩改善，四季度有望迎来业绩拐点",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-11-04 00:00:00.000",
      "infoCode": "AP202211041579947570",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1142,
      "attachPages": 4,
      "encodeUrl": "xLXppbsR8JK6IVDQLZUo+WAw3icYvpFi/dAA560YBeE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "Q3收入降幅收窄，创新研发加速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-10-31 00:00:00.000",
      "infoCode": "AP202210311579646243",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1058,
      "attachPages": 4,
      "encodeUrl": "h4O6cVihvXMgf8ULIuPRoNrAUI/lKICqufYYs+Jo6Is=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2022年三季报点评：边际改善明显，创新持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2022-10-30 00:00:00.000",
      "infoCode": "AP202210301579634736",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 490,
      "attachPages": 3,
      "encodeUrl": "hgrXh9eRwp5Sj0r8XOb76SaDDFyHl7uL8i+TEIinbzI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "黎明将至，“创新+国际化”引领新征程",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2022-09-13 00:00:00.000",
      "infoCode": "AP202209131578361441",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2065,
      "attachPages": 29,
      "encodeUrl": "1tx03RaJyk1PuB+zdSeGkLv6xv8Albf5FlDsW+6xbAg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2022年中报点评：坚定加大研发投入，有力支撑长远发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2022-08-24 00:00:00.000",
      "infoCode": "AP202208241577550289",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 467,
      "attachPages": 3,
      "encodeUrl": "usUt8QHVisyrE9M5EdZJP0sP2jDzVBKAPrWMUdh36qY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "上半年业绩承压，创新+国际化战略稳步推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2022-08-23 00:00:00.000",
      "infoCode": "AP202208231577484818",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 850,
      "attachPages": 4,
      "encodeUrl": "aNoJOmsShYfriS7vFg3DyVD3LTqwbbmerxPfnLKblDs=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "集采短期影响持续，创新研发加速推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-08-22 00:00:00.000",
      "infoCode": "AP202208221577441955",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1188,
      "attachPages": 4,
      "encodeUrl": "aBXgaMsDZosMRq5rUoOxncWfHyKpq1+mgFmpklTO30s=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "短期业绩承压，加速推进创新转型",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-08-22 00:00:00.000",
      "infoCode": "AP202208221577441798",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1191,
      "attachPages": 4,
      "encodeUrl": "aBXgaMsDZosMRq5rUoOxnRFGOfM7TU2aBhBYMnIPDrg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "瑞维鲁胺片获批，创新药逐步迎来收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-06-30 00:00:00.000",
      "infoCode": "AP202206301575648526",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1185,
      "attachPages": 4,
      "encodeUrl": "dNLZeCOhhiFA469cr2DCjHDLzPQF0L09epTBxU0yOsA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "瑞维鲁胺片获批上市，创新管线持续兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2022-06-30 00:00:00.000",
      "infoCode": "AP202206301575585179",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1128,
      "attachPages": 4,
      "encodeUrl": "dNLZeCOhhiFA469cr2DCjJ++nh3xks0U64zZgxjsu6s=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "海曲泊帕获FDA孤儿药认定，创新转型与国际化持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2022-06-15 00:00:00.000",
      "infoCode": "AP202206151572309930",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班"
      ],
      "indvIsNew": "001",
      "researcher": "王班",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1184,
      "attachPages": 4,
      "encodeUrl": "SaslGUJQaiJu9EuLaXsMIhR1VnvXH4X/gUTs+24lRDA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136"
      ],
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 2,
  "currentYear": 2025
}